Seminars in dialysis
-
Seminars in dialysis · May 2014
Randomized Controlled Trial Multicenter Study Comparative StudyA comparison between the HeRO graft and conventional arteriovenous grafts in hemodialysis patients.
Venous stenosis and occlusion are a major cause of vascular access dysfunction and failure. The HeRO Graft bypasses occlusion and traverses stenosis with outflow directly into the central venous circulation. A randomized, multicenter study was conducted to evaluate the efficacy and safety of the HeRO Graft relative to conventional AV grafts. ⋯ The rates of intervention were 2.2/year for HeRO Graft and 1.6/year for the control (p = 0.100). Median days to loss of secondary patency was 238 for HeRO Graft versus 102 for the control (p = 0.032). The HeRO Graft appears to provide similar patency, adequacy of dialysis, and bacteremia rates to those of conventional AV grafts.
-
Seminars in dialysis · May 2001
Randomized Controlled Trial Comparative Study Clinical TrialEffects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial, by Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, and La Greca G. Lancet 355:26-30, 2000.